Related Experiment Videos
Early plasmacytoid dendritic cell changes predict plasma HIV load rebound during primary infection
Jerome Pacanowski1, Leyla Develioglu, Isabelle Kamga
1Département de Maladies Infectieuses et Tropicales, Hôpital St. Antoine, Assistance Publique--Hopitaux de Paris, Universite Paris VI, Paris, France.
The Journal of Infectious Diseases
|October 23, 2004
Summary
Plasmacytoid dendritic cell (pDC) counts during highly active antiretroviral therapy (HAART) may predict viral load control after treatment interruption in primary HIV-1 infection. Higher pDC levels correlate with better immune control, suggesting their role in managing HIV replication.
Area of Science:
- Immunology
- Virology
- Infectious Diseases
Background:
- Human immunodeficiency virus (HIV) infection often leads to viral rebound upon interruption of highly active antiretroviral therapy (HAART).
- Plasmacytoid dendritic cells (pDCs) are implicated in innate immunity against HIV.
- Understanding factors predicting viral control post-HAART is crucial for HIV management.
Purpose of the Study:
- To investigate the relationship between plasmacytoid dendritic cell (pDC) counts and viral load dynamics during and after highly active antiretroviral therapy (HAART) in primary HIV-1 infection.
- To determine if pDC levels can predict immune control after HAART interruption.
Main Methods:
- Flow cytometry was used to quantify pDC numbers in 7 patients with primary HIV-1 infection.
- pDC counts were measured before, during, and after HAART.
- Plasma viral load was assessed after HAART interruption.
Main Results:
- A significant negative correlation was found between pDC counts after one month of HAART and mean plasma viral load after HAART interruption (r²=0.85; P=.03).
- Higher pDC counts during HAART were associated with lower viral loads upon treatment cessation.
Conclusions:
- pDC counts during HAART may serve as a predictive marker for immune-mediated viral replication control after treatment interruption in HIV-1 infection.
- These findings highlight the potential role of pDCs in maintaining viral suppression in the absence of therapy.